公开(公告)号：US20240228488A1

公开(公告)日：2024-07-11

申请号：US18550306

申请日：2022-03-16

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： Nikolaos PAPAIOANNOU ,  Jeremy Mark TRAVINS ,  Sarah Jocelyn FINK ,  John Mark ELLARD ,  Alastair RAE ,  Jonathan Andrew SPENCER ,  Stuart Shane RANKIN ,  Robert Staurt Laurie CHAPMAN

IPC: C07D471/04 ,  C07D519/00

CPC classification number: C07D471/04 ,  C07D519/00

Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.

公开(公告)号：US20240382482A1

公开(公告)日：2024-11-21

申请号：US18550571

申请日：2022-03-16

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： Nikolaos PAPAIOANNOU ,  Jeremy Mark TRAVINS ,  Sarah Jocelyn FINK ,  John Mark ELLARD ,  Alastair RAE ,  Jonathan Andrew SPENCER

IPC: A61K31/506 ,  C07D519/00

Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.

公开(公告)号：US20240199613A1

公开(公告)日：2024-06-20

申请号：US18550486

申请日：2022-03-16

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： Nikolaos PAPAIOANNOU ,  Jeremy Mark TRAVINS ,  Sarah Jocelyn FINK ,  John Mark ELLARD ,  Alastair RAE ,  Stuart Shane RANKIN ,  Robert Staurt Laurie CHAPMAN

IPC: C07D471/04 ,  C07D519/00

CPC classification number: C07D471/04 ,  C07D519/00

Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.